Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07118124 · ClinicalTrials.gov registry record · NA

Pediatric Adhesion and New Dermal Approach Study

A NA study of Congenital Heart Disease and Arrhythmia, sponsored by iRhythm Technologies.

Active
Registry status
NA
Development phase
36
Enrollment target
4
Study locations

NCT07118124 is a NA study of Congenital Heart Disease and Arrhythmia that is active but no longer recruiting, run by iRhythm Technologies. The registered enrollment target is 36 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07118124, a NA study of Congenital Heart Disease and Arrhythmia, is active but no longer recruiting, sponsored by iRhythm Technologies.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to see if the Zio® monitor device can be worn by children for up to 14-days and to determine if the skin preparation process will provide good adherence to the skin and clear signal quality. The Zio® monitor (Study Device) is an adhesive patch that is worn on the upper left chest for a specified period of time and is similar to a band aid. The Study Device contains a battery-powered heart monitor and will look at the heart rhythm and rate.

Conditions Studied

Congenital Heart Disease Arrhythmia Syncope Pediatric Congenital Athymia Arrhythmia in Children

Interventions

  • DEVICE Zio monitor

Study Locations (4)

District of Columbia

  • Children's National Hospital - Washington D.C.

Idaho

  • St. Luke's Children's Hospital - Boise

Massachusetts

  • Boston Children's Hospital - Boston

Missouri

  • WashU Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-08-15
Est. Completion 2026-03
Phase NA

Sponsor

iRhythm Technologies

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07118124

The ClinicalTrials.gov registry entry for NCT07118124 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The listed sponsor is iRhythm Technologies, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Zio monitor is the first listed.

NCT07118124 reports 4 study locations spanning 4 distinct geographic areas - top geographies include District of Columbia, Idaho, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07118124 about?

NCT07118124 is a clinical study titled "Pediatric Adhesion and New Dermal Approach Study". The purpose of this study is to see if the Zio® monitor device can be worn by children for up to 14-days and to determine if the skin preparation process will provide good adherence to the skin and clear signal quality. The Zio® monitor (Study Device) is an adhesive patch that is worn on the upper l...

What is the current status of trial NCT07118124?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-08-15. Estimated completion is 2026-03.

What conditions does trial NCT07118124 study?

This clinical trial studies the following conditions: Congenital Heart Disease, Arrhythmia, Syncope, Pediatric, Congenital Athymia.

What interventions are being tested in trial NCT07118124?

The interventions under investigation include: Zio monitor (DEVICE).

Who is sponsoring clinical trial NCT07118124?

This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07118124 being conducted?

This trial has 4 study locations across District of Columbia, Idaho, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Congenital Heart Disease

All registered trials for this condition

Arrhythmia

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.